Finnrick - Ensuring a Safer and More Transparent Supply Chain
P3 Labz

P3 Labz

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from P3 Labz between 6 Oct 2025 and 29 Jan 2026. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).

Finnrick Rating™
P3 Labz
Tirzepatide
Tested 6 Samples
Last test 29 Jan 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from P3 Labz

Samples are tested in commercial labs

Tests Count

6

Scores

AVG8.8MIN5.6MAX10.0

Last

29 Jan 2026

First

6 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
29 Jan 2026View10.030mg29.7mg-1.0%99.90%30-1023UTSilver Label / Black Crimp / Clear Blue CapLab EPublic
29 Jan 2026View9.830mg31.7mg+5.7%99.90%ZE30-1005Silver Label / Black Crimp / Yellow CapLab EPublic
29 Jan 2026View10.045mg46.9mg+4.2%99.90%ZE45-1113Silver Label / Black Crimp / White CapLab EPublic
29 Jan 2026View9.460mg64.1mg+6.8%99.90%ZE60-1123Silver Label / Gold Crimp / Clear Red CapLab EPublic
29 Jan 2026View8.230mg26.6mg-11.3%99.90%M3POS01-100Silver Label / Silver Crimp / Pink CapLab EPublic
6 Oct 2025View5.630mg37mg+23.3%99.30%6-2205-1Silver Label / Silver Crimp / Violet Cap Lab GPublic